+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Menopausal Hot Flashes Market 2020-2024 - Product Image

Global Menopausal Hot Flashes Market 2020-2024

  • ID: 5157095
  • Report
  • August 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • MORE
Global Menopausal Hot Flashes Market 2020-2024

The menopausal hot flashes market is poised to grow by $ 727.10 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The reports on the menopausal hot flashes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the change in lifestyle and increase of women in workforce. In addition, change in lifestyle is anticipated to boost the growth of the market as well.

The menopausal hot flashes market analysis includes distribution channel segment and geographical landscapes.

The menopausal hot flashes market is segmented as below:

By Distribution Channel
  • Retail outlets
  • Online stores
By Geographical Landscapes
  • North America
  • Europe
  • APAC
  • South America
  • MEA
This study identifies the rise in disposable income as one of the prime reasons driving the menopausal hot flashes market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The menopausal hot flashes market covers the following areas:
  • Menopausal hot flashes market sizing
  • Menopausal hot flashes market forecast
  • Menopausal hot flashes market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading menopausal hot flashes market vendors that include AbbVie Inc., Bayer AG, GlaxoSmithKline Plc, Hisamitsu Pharmaceutical Co. Inc., Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. Also, the menopausal hot flashes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • MORE
Executive Summary
  • Market Overview
Market Landscape

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Distribution channel
  • Market segments
  • Comparison by Distribution channel
  • Retail outlets - Market size and forecast 2019-2024
  • Online stores - Market size and forecast 2019-2024
  • Market opportunity by Distribution channel
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Hisamitsu Pharmaceutical Co. Inc.
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Distribution channel - Market share 2019-2024 (%)
22: Comparison by Distribution channel
23: Retail outlets - Market size and forecast 2019-2024 ($ million)
24: Retail outlets - Year-over-year growth 2019-2024 (%)
25: Online stores - Market size and forecast 2019-2024 ($ million)
26: Online stores - Year-over-year growth 2019-2024 (%)
27: Market opportunity by Distribution channel
28: Customer Landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: North America - Market size and forecast 2019-2024 ($ million)
32: North America - Year-over-year growth 2019-2024 (%)
33: Europe - Market size and forecast 2019-2024 ($ million)
34: Europe - Year-over-year growth 2019-2024 (%)
35: APAC - Market size and forecast 2019-2024 ($ million)
36: APAC - Year-over-year growth 2019-2024 (%)
37: South America - Market size and forecast 2019-2024 ($ million)
38: South America - Year-over-year growth 2019-2024 (%)
39: MEA - Market size and forecast 2019-2024 ($ million)
40: MEA - Year-over-year growth 2019-2024 (%)
41: Key leading countries
42: Market opportunity by geography ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: AbbVie Inc. - Overview
50: AbbVie Inc. - Business segments
51: AbbVie Inc. - Key offerings
52: AbbVie Inc. - Key customers
53: AbbVie Inc. - Segment focus
54: Bayer AG - Overview
55: Bayer AG - Business segments
56: Bayer AG - Key offerings
57: Bayer AG - Key customers
58: Bayer AG - Segment focus
59: GlaxoSmithKline Plc - Overview
60: GlaxoSmithKline Plc - Business segments
61: GlaxoSmithKline Plc - Key offerings
62: GlaxoSmithKline Plc - Key customers
63: GlaxoSmithKline Plc - Segment focus
64: Hisamitsu Pharmaceutical Co. Inc. - Overview
65: Hisamitsu Pharmaceutical Co. Inc. - Business segments
66: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
67: Hisamitsu Pharmaceutical Co. Inc. - Key customers
68: Hisamitsu Pharmaceutical Co. Inc. - Segment focus
69: Merck KGaA - Overview
70: Merck KGaA - Business segments
71: Merck KGaA - Key offerings
72: Merck KGaA - Key customers
73: Merck KGaA - Segment focus
74: Mylan NV - Overview
75: Mylan NV - Business segments
76: Mylan NV - Key offerings
77: Mylan NV - Key customers
78: Mylan NV - Segment focus
79: Novartis AG - Overview
80: Novartis AG - Business segments
81: Novartis AG - Key offerings
82: Novartis AG - Key customers
83: Novartis AG - Segment focus
84: Novo Nordisk AS - Overview
85: Novo Nordisk AS - Business segments
86: Novo Nordisk AS - Key offerings
87: Novo Nordisk AS - Key customers
88: Novo Nordisk AS - Segment focus
89: Pfizer Inc. - Overview
90: Pfizer Inc. - Business segments
91: Pfizer Inc. - Key offerings
92: Pfizer Inc. - Key customers
93: Pfizer Inc. - Segment focus
94: Teva Pharmaceutical Industries Ltd. - Overview
95: Teva Pharmaceutical Industries Ltd. - Business segments
96: Teva Pharmaceutical Industries Ltd. - Key offerings
97: Teva Pharmaceutical Industries Ltd. - Key customers
98: Teva Pharmaceutical Industries Ltd. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • MORE
The publisher recognizes the following companies as the key players in the global menopausal hot flashes market: AbbVie Inc., Bayer AG, GlaxoSmithKline Plc, Hisamitsu Pharmaceutical Co. Inc., Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in disposable income."

According to the report, one of the major drivers for this market is the change in lifestyle.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Hisamitsu Pharmaceutical Co. Inc.
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll